标题
Partial PTEN deletion is linked to poor prognosis in breast cancer
作者
关键词
Breast cancer, <em class=EmphasisTypeItalic >PTEN</em>, FISH, Prognosis
出版物
BMC CANCER
Volume 15, Issue 1, Pages -
出版商
Springer Nature
发表日期
2015-12-17
DOI
10.1186/s12885-015-1770-3
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Clinical significance of p95HER2 overexpression, PTEN loss and PI3K expression in p185HER2-positive metastatic breast cancer patients treated with trastuzumab-based therapies
- (2014) D Tural et al. BRITISH JOURNAL OF CANCER
- Clinical significance of different types ofp53gene alteration in surgically treated prostate cancer
- (2014) Martina Kluth et al. INTERNATIONAL JOURNAL OF CANCER
- Comparison of the Characteristics of Medullary Breast Carcinoma and Invasive Ductal Carcinoma
- (2014) Inhye Park et al. Journal of Breast Cancer
- Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities
- (2014) M. V. Dieci et al. ONCOLOGIST
- Clinical and Prognostic Significance of HIF-1α, PTEN, CD44v6, and Survivin for Gastric Cancer: A Meta-Analysis
- (2014) Jing Chen et al. PLoS One
- Estrogen Induces Vav1 Expression in Human Breast Cancer Cells
- (2014) Ming-juan Du et al. PLoS One
- The Validation and Clinical Implementation of BRCAplus: A Comprehensive High-Risk Breast Cancer Diagnostic Assay
- (2014) Hansook Kim Chong et al. PLoS One
- Role of HER3 expression and PTEN loss in patients with HER2-overexpressing metastatic breast cancer (MBC) who received taxane plus trastuzumab treatment
- (2013) Y H Park et al. BRITISH JOURNAL OF CANCER
- CHD1 Is a 5q21 Tumor Suppressor Required for ERG Rearrangement in Prostate Cancer
- (2013) L. Burkhardt et al. CANCER RESEARCH
- Molecular determinants of trastuzumab efficacy: What is their clinical relevance?
- (2013) Pradip De et al. CANCER TREATMENT REVIEWS
- The predictive role of phosphatase and tensin homolog (PTEN) loss, phosphoinositol-3 (PI3) kinase (PIK3CA) mutation, and PI3K pathway activation in sensitivity to trastuzumab in HER2-positive breast cancer: a meta-analysis
- (2013) Yaohui Wang et al. CURRENT MEDICAL RESEARCH AND OPINION
- Comprehensive analysis of PTEN status in breast carcinomas
- (2013) Natalie Jones et al. INTERNATIONAL JOURNAL OF CANCER
- Recurrent deletion of 3p13 targets multiple tumour suppressor genes and defines a distinct subgroup of aggressiveERGfusion-positive prostate cancers
- (2013) Antje Krohn et al. JOURNAL OF PATHOLOGY
- Genomic deletion of MAP3K7 at 6q12-22 is associated with early PSA recurrence in prostate cancer and absence of TMPRSS2:ERG fusions
- (2013) Martina Kluth et al. MODERN PATHOLOGY
- Genomic Deletion of PTEN Is Associated with Tumor Progression and Early PSA Recurrence in ERG Fusion-Positive and Fusion-Negative Prostate Cancer
- (2012) Antje Krohn et al. AMERICAN JOURNAL OF PATHOLOGY
- Increased signalling of EGFR and IGF1R and deregulation of PTEN/PI3K/Akt pathway are related with trastuzumab resistance in HER2 breast carcinomas
- (2012) A Gallardo et al. BRITISH JOURNAL OF CANCER
- MYC Acts via the PTEN Tumor Suppressor to Elicit Autoregulation and Genome-Wide Gene Repression by Activation of the Ezh2 Methyltransferase
- (2012) M. Kaur et al. CANCER RESEARCH
- Loss of Heterozygosity at Tumor Suppressor Genes Detectable on Fractionated Circulating Cell-Free Tumor DNA as Indicator of Breast Cancer Progression
- (2012) H. Schwarzenbach et al. CLINICAL CANCER RESEARCH
- Insulin growth factor receptor-1 expression and loss of PTEN protein predict early recurrence in triple-negative breast cancer
- (2012) Jabed Iqbal et al. HISTOPATHOLOGY
- Exome Enrichment and SOLiD Sequencing of Formalin Fixed Paraffin Embedded (FFPE) Prostate Cancer Tissue
- (2012) Roopika Menon et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Retinoblastoma and Phosphate and Tensin Homolog Tumor Suppressors: Impact on Ductal Carcinoma In Situ Progression
- (2012) Erik S. Knudsen et al. JNCI-Journal of the National Cancer Institute
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- Evaluation of the association of PIK3CA mutations and PTEN loss with efficacy of trastuzumab therapy in metastatic breast cancer
- (2011) E. Razis et al. BREAST CANCER RESEARCH AND TREATMENT
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- MGMT and PTEN as potential prognostic markers in breast cancer
- (2011) Julio Cirullo Neto et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- PTEN, PIK3CA, p-AKT, and p-p70S6K Status
- (2010) Francisco J. Esteva et al. AMERICAN JOURNAL OF PATHOLOGY
- Distinguishing medullary carcinoma of the breast from high-grade hormone receptor-negative invasive ductal carcinoma: an immunohistochemical approach
- (2010) Uta Flucke et al. HISTOPATHOLOGY
- Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis
- (2010) Wendy De Roock et al. LANCET ONCOLOGY
- EGFR, pMAPK, pAkt and PTEN status by immunohistochemistry: correlation with clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab
- (2009) S. Gori et al. ANNALS OF ONCOLOGY
- Array comparative genomic hybridization identifies genetic regions associated with outcome in aggressive diffuse large B-cell lymphomas
- (2009) Cristina Robledo et al. CANCER
- PI3K pathway activation in breast cancer is associated with the basal-like phenotype and cancer-specific mortality
- (2009) Elena López-Knowles et al. INTERNATIONAL JOURNAL OF CANCER
- Cooperativity of TMPRSS2-ERG with PI3-kinase pathway activation in prostate oncogenesis
- (2009) Jennifer C King et al. NATURE GENETICS
- Aberrant ERG expression cooperates with loss of PTEN to promote cancer progression in the prostate
- (2009) Brett S Carver et al. NATURE GENETICS
- PTEN expression is a strong predictor of survival in mesothelioma patients☆
- (2008) Isabelle Opitz et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Breast Tumor Cells with PI3K Mutation or HER2 Amplification Are Selectively Addicted to Akt Signaling
- (2008) Qing-Bai She et al. PLoS One
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started